Correlation Between Blueberries Medical and Cannara Biotech

Can any of the company-specific risk be diversified away by investing in both Blueberries Medical and Cannara Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueberries Medical and Cannara Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Blueberries Medical Corp and Cannara Biotech, you can compare the effects of market volatilities on Blueberries Medical and Cannara Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueberries Medical with a short position of Cannara Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueberries Medical and Cannara Biotech.

Diversification Opportunities for Blueberries Medical and Cannara Biotech

-0.49

Correlation Coefficient

Blueberries Medical  Cannara Biotech

Very good diversification

The 3 months correlation between Blueberries and Cannara is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Blueberries Medical Corp and Cannara Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannara Biotech and Blueberries Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueberries Medical Corp are associated (or correlated) with Cannara Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannara Biotech has no effect on the direction of Blueberries Medical i.e., Blueberries Medical and Cannara Biotech go up and down completely randomly.

Pair Corralation between Blueberries Medical and Cannara Biotech

Assuming the 90 days horizon Blueberries Medical Corp is expected to generate 2.82 times more return on investment than Cannara Biotech. However, Blueberries Medical is 2.82 times more volatile than Cannara Biotech. It trades about 0.05 of its potential returns per unit of risk. Cannara Biotech is currently generating about 0.01 per unit of risk. If you would invest  1.73  in Blueberries Medical Corp on September 29, 2024 and sell it today you would lose (0.65) from holding Blueberries Medical Corp or give up 37.57% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	99.6%
Values	Daily Returns

Blueberries Medical Corp  vs.  Cannara Biotech

Blueberries Medical Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Blueberries Medical Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Blueberries Medical is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders.

Cannara Biotech

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent technical and fundamental indicators, Cannara Biotech reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Blueberries Medical and Cannara Biotech

The main advantage of trading using opposite Blueberries Medical and Cannara Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueberries Medical position performs unexpectedly, Cannara Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannara Biotech will offset losses from the drop in Cannara Biotech's long position.

The idea behind Blueberries Medical Corp and Cannara Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.